The second extraordinary meeting of the 7th Board of Directors of Innovation Medical Management Co., Ltd. was held on April 28, 2026. The board unanimously approved the Q1 2026 report and a guarantee for Zhejiang Hongrun Pharmaceutical Co., Ltd. to secure a loan of up to 8 million yuan from China Merchants Bank. This decision aims to support the operational needs and business development of Zhejiang Hongrun Pharmaceutical.
Summary generated by AI · Always verify with source document
Innovation Medical Management Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.